市場調查報告書
商品編碼
1433334
全球軟骨修復市場2023-2030Global Cartilage Repair Market 2023-2030 |
預計全球軟骨修復市場在預測期(2023-2030年)將以5.2%的CAGR成長。骨關節炎等骨關節疾病發病率的增加以及軟骨再生技術的進步推動了市場的成長。骨關節炎盛行率的增加歸因於老年人口的不斷擴大以及肥胖和其他相關因素的影響不斷加大等因素。根據世界衛生組織統計,2019年,全球約有5.28億人患有骨關節炎,自1990年以來增加了113%。約73%的骨關節炎患者年齡超過55歲,其中60%是女性。膝關節的盛行率高達 3.65 億,是最常受影響的關節,其次是髖關節和手部。
全球軟骨修復市場依模式、應用部位、應用程式和最終用戶進行區隔。根據模式,市場分為基於細胞的和基於非細胞的。根據應用部位,市場可區隔為踝關節、足部、膝關節和髖關節。根據應用,市場分為透明軟骨和纖維軟骨。此外,根據最終用戶,市場分為醫院和門診手術中心。在這些治療方式中,由於人們越來越傾向於將自體軟骨細胞移植作為受損關節軟骨(包括軟骨和骨軟骨病變)的手術治療方法,因此基於細胞的區隔市場預計將佔據相當大的市場佔有率。
在應用領域中,膝關節區隔市場預計將在全球軟骨修復市場中佔據相當大的佔有率。膝蓋手術有多種因素造成,包括人口老化、研發活動投資、對微創手術的日益偏好、道路事故和運動相關傷害的增加。根據關節鏡、運動醫學和復健中心的數據,在這項研究中,21% 的球員發生了結構性膝關節損傷,每 1,000 場比賽中總體受傷率為 5.42 例。依年齡分層,結構性膝關節損傷發生率在20歲以下的球員中最高(3.23/1000 GE),其次是30歲以下(3.11/1000 GE)、25至29歲(2.97/1000 GE)和20歲以下。至 24 年 (2.26/100 GE)。以每場比賽分鐘數計算,膝傷發生率最高的是上場時間超過30 分鐘的球員(3.86/1000 GE),其次是20.0 至29.9 分鐘(3.03/1000 GE)和10.0 至19.9 分鐘(1.82/1000 GE)。
全球軟骨修復市場根據地理位置進一步區隔,包括北美(美國和加拿大)、歐洲(英國、義大利、西班牙、德國、法國和歐洲其他地區)、亞太地區(印度、中國、日本) 、韓國和亞洲其他地區)以及世界其他地區(中東和非洲以及拉丁美洲)。其中,由於治療率上升、藥品價格上漲,預計亞太地區在預測年內將出現成長價格、先進的醫療技術、不斷成長的可支配收入以及新興經濟體不斷改善的醫療基礎設施正在推動亞太地區的軟骨修復市場。
在所有地區中,北美地區預計在預測期內將以相當大的CAGR成長。由於骨關節炎發病率上升、政府的積極舉措和高度發達的醫療基礎設施等因素,北美市場正在不斷成長。根據美國疾病管制與預防中心的數據,2019 年至 2021 年期間,約五分之一的美國成年人(21.2%)或約 5,320 萬人患有醫生診斷的關節炎。與男性 (16.3%) 相比,女性 (20.9%) 更容易患關節炎。因此,骨關節炎發生率的增加預計將推動對軟骨修復和再生產品的需求。
服務軟骨修復市場的主要公司包括 Zimmer Biomet Holdings, Inc.、Conmed Corp.、Stryker Corp.、Osiris Therapeutics, Inc.、Smith & Nephew Plc、Arthrex, Inc、RTI Surgical, Inc. 等。市場參與者透過各種策略(包括併購、合作、合作、融資和新產品發布),為市場成長做出了巨大貢獻,以保持市場競爭力。例如,2023 年 8 月,Marrow Access Technologies 與 Spartan Medical 簽署了分銷協議。該分銷協議為退伍軍人事務部(VA) 和國防部(DoD) 的患者提供了使用SmartShot (R) 骨髓訪問設備的機會,這是一種利用人體自身幹細胞和癒合能力來治療骨科軟組織的新解決方案肩膀、臀部、膝蓋、腳踝和腳部受傷。
Global Cartilage Repair Market Size, Share & Trends Analysis Report by Types of Colorectal Cancer (Cell Based and Non-Cell Based), by Application Site (Ankle, Foot, Knee, and Hip), by Application (Hyaline Cartilage and Fibrocartilage), and by End-User (Hospitals and Ambulatory Surgical Centers), Forecast Period (2023-2030)
The global cartilage repair market is anticipated to grow at a CAGR of 5.2% during the forecast period (2023-2030). The market growth is driven by the increasing incidence of bone and joint disorders, such as osteoarthritis, as well as advancements in cartilage regeneration technology. The increasing prevalence of osteoarthritis is attributed to factors such as the expanding geriatric population and the rising impact of obesity and other related factors. According to the WHO, in 2019, about 528 million people around the globe were living with osteoarthritis, an increase of 113% since 1990. About 73% of people living with osteoarthritis are older than 55 years, and 60% are female. With a prevalence of 365 million, the knee is the most frequently affected joint, followed by the hip and the hand.
The global cartilage repair market is segmented on the modality, application site, application, and end-user. Based on the modality, the market is sub-segmented into cell based and non-cell based. Based on the application site, the market is sub-segmented into ankle, foot, knee, and hip. Based on the application, the market is sub-segmented into hyaline cartilage and fibrocartilage. Further, based on end user, the market is sub-segmented into hospitals and ambulatory surgical centers. Among the modality, the cell based sub-segment is anticipated to hold a considerable share of the market, owing to the growing preference for autologous chondrocyte transplants as a surgical treatment for damaged articular cartilage, including chondral and osteochondral lesions.
Among the application site, the Knee sub-segment is expected to hold a considerable share of the global cartilage repair market. Various factors are attributed to the knee surgery including the increasing ageing population, investments in research and development activities, the growing preference for minimally invasive procedures, rising road accidents and sports-related injuries. According to the Arthroscopy, Sports Medicine, and Rehabilitation, structural knee injuries occurred in 21% of players in this study with an overall rate of 5.42 injuries per 1,000 game exposures. Stratified by age, structural knee injury rate was greatest in players less than 20 years old (3.23/1000 GE) followed by less than 30 years old (3.11/1000 GE), 25 to 29 years (2.97/1000 GE), and 20 to 24 years (2.26/100 GE). Knee injury by minutes per game, the rate was greatest in those playing more than 30 minutes (3.86/1000 GE), followed by 20.0 to 29.9 minutes (3.03/1000 GE), and 10.0 to 19.9 minutes (1.82/1000 GE).
The global cartilage repair market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Asia pacific is anticipated to grow over the forecast year, owing to the rising treatment rates, inflated medicine prices, advanced medical technologies, the rising disposable income coupled with improving healthcare infrastructure in emerging economies are driving the cartilage repair market in the Asia Pacific.
Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. The North America market is growing owing to factors including the rising incidence of osteoarthritis, favorable government initiatives and highly developed healthcare infrastructure. According to the Centers for Disease Control and Prevention, during 2019-2021, about 1 in 5 US adults (21.2%) or about 53.2 million people had doctor-diagnosed arthritis. Arthritis was more common among women (20.9%) compared to men (16.3%). Thus, the increasing incidence of osteoarthritis is expected to drive the demand for cartilage repair and regeneration products.
The major companies serving the cartilage repair market include Zimmer Biomet Holdings, Inc., Conmed Corp., Stryker Corp., Osiris Therapeutics, Inc., Smith & Nephew Plc, Arthrex, Inc, RTI Surgical, Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in August 2023, Marrow Access Technologies signed a distribution agreement with Spartan Medical. The distribution agreement offered patients in the Department of Veterans Affairs (VA) and Department of Defense (DoD) access to the SmartShot® Marrow Access Device, a new solution for using the body's own stem cells and healing capabilities to treat orthopedic soft tissue injuries of the shoulder, hip, knee, ankle, and foot.